Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Nat Microbiol. 2022 Oct 31;7(12):1956–1966. doi: 10.1038/s41564-022-01243-4

Table 1.

Summary of phage mutants engineered by CRISPR-Cas13a.

Phage Gene No./Genomic site Identified protein Modification % plaques acrVIA1+1 (n2) Desired mutant isolated?
ФKZ Upstream of orf54 - Insertion 41.2% (17) Yes
Downstream of orf120 - Insertion 50.0% (16)
orf39 PhuZ Deletion 52.9% (17)
mNeonGreen-PhuZ fusion 25.0% (16)
mCherry-PhuZ
fusion
25.0% (16)
orf93 Inner body protein Deletion 20.0% (20)
gp93-mNeonGreen fusion 18.2% (22)
orf241 Hypothetical Deletion 26.1% (23)
orf241, orf242 Hypothetical Double deletions 41.7% (12)
orf54 Shell Deletion 20.0% (15) No
mCherry-gp54
fusion
8.3% (24)
gp54-mCherry
fusion
9.1% (11)
gfp11-gp54 fusion 7.0% (57)
orf89, orf90,
orf91, orf92, orf93
Inner body proteins Deletion 11.8% (17)
orf146 Structural protein Deletion 0% (89)
OMKO1 Downstream of the capsid gene - Insertion with a barcode 70.8% (24) Yes
Upstream of the shell gene - Insertion 50.0% (12)
PaMx41 orf24 Hypothetical Deletion 100.0% (8) Yes
1

Percentage of PCR-identified recombinants out of all tested plaques.

2

Number of plaques analyzed by PCR to screen for recombinants.